Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 2,053.58 and traded as high as GBX 2,328. Johnson Matthey shares last traded at GBX 2,248, with a volume of 267,031 shares.
Analyst Ratings Changes
A number of research analysts have recently weighed in on the company. Jefferies Financial Group restated a “buy” rating and set a GBX 2,330 price objective on shares of Johnson Matthey in a research report on Tuesday, August 4th. Berenberg Bank boosted their target price on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the stock a “buy” rating in a research report on Monday, June 1st. UBS Group reissued a “neutral” rating and set a GBX 2,200 price target on shares of Johnson Matthey in a research note on Friday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 2,400 price target on shares of Johnson Matthey in a report on Monday, July 6th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of GBX 2,283.33.
Check Out Our Latest Stock Report on Johnson Matthey
Johnson Matthey Stock Down 0.1%
Insider Activity
In related news, insider Alastair Judge acquired 12 shares of Johnson Matthey stock in a transaction on Wednesday, August 12th. The shares were bought at an average cost of GBX 2,193 per share, with a total value of £263.16. Also, insider Liam Condon acquired 14 shares of Johnson Matthey stock in a transaction on Friday, July 10th. The shares were bought at an average cost of GBX 1,909 per share, for a total transaction of £267.26. In the last three months, insiders have acquired 17,685 shares of company stock worth $39,742,338. 0.74% of the stock is currently owned by corporate insiders.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Further Reading
- Five stocks we like better than Johnson Matthey
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
